Ying Guo

Ying Guo is a Senior Director of Biostatistics at Gilead Sciences, where they have amassed over 11 years of experience in drug development with a focus on inflammation and respiratory therapeutic areas. Ying has served as the statistical program lead on multiple early and late development programs and has extensive experience with regulatory interactions, including the successful submission and approval of Figotinib (Jyseleca) for Rheumatoid Arthritis. Prior to their current role, they held various positions at Gilead Sciences, progressing from Senior Manager to Senior Director, and previously worked as a Biometrician at Merck Sharp & Dohme. Ying earned a Ph.D. in Missing Data and Bayesian Statistics from the University of Michigan.